Form D Explorer

Inspect source fieldsReport a record issue

Form D — Paulex Bio Inc.

0001493152-25-028344 · filed Dec 18, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(c)
Reported offering amount
$22,500,000
Reported amount sold
$18,516,040
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Paulex Bio Inc.
CIK
2071082
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2023
Address
6083 OAKGATE ROW
LA JOLLA, California 92037
Phone
202-308-3507

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗